Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2.

Lymph node excision Lymph nodes Uterine cervical neoplasms

Journal

Obstetrics & gynecology science
ISSN: 2287-8572
Titre abrégé: Obstet Gynecol Sci
Pays: Korea (South)
ID NLM: 101602614

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 07 01 2020
accepted: 15 09 2020
pubmed: 4 11 2020
medline: 4 11 2020
entrez: 3 11 2020
Statut: ppublish

Résumé

To investigate clinical features that affect the number of pelvic lymph nodes (PLNs) harvested and prognostic significance of the number of PLNs removed in patients with stage IB1 to IIA2 cervical cancer. Data from patients with cervical cancer whom underwent hysterectomy with PLN dissection between June 2004 and July 2015 were reviewed retrospectively. Data on clinicopathologic factors including age, height, and weight were collected. Data on the presence of PLN metastasis on imaging studies prior to surgery, number of PLNs harvested, and presence of metastasis in the harvested PLNs were retrieved from medical records. Clinical features associated with the number of PLNs harvested were analyzed. Disease-free survival (DFS) and overall survival (OS) according to the number of PLNs harvested were analyzed. During the study period, 210 patients were included. The height and weight of patients and preoperative positive positron emission tomography findings were significantly associated with a higher number of PLNs harvested. As a pathologic factor, larger tumor size was associated with a higher number of PLNs harvested. Furthermore, a higher number of PLNs harvested was associated with a higher number of metastatic PLNs and patients undergoing postoperative concurrent chemoradiation therapy. Patient height and tumor size were independent factors affecting the number of PLNs harvested in multivariate analysis. However, the number of PLNs harvested was not associated with DFS or OS. The number of PLNs harvested during surgery was associated with patient height; however, this was not related to the prognosis of the disease.

Identifiants

pubmed: 33137864
pii: ogs.20016
doi: 10.5468/ogs.20016
pmc: PMC7834762
doi:

Types de publication

Journal Article

Langues

eng

Pagination

73-79

Références

Curr Med Sci. 2018 Aug;38(4):567-574
pubmed: 30128863
J Clin Oncol. 2000 Apr;18(8):1606-13
pubmed: 10764420
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
J Obstet Gynaecol Res. 2017 Jan;43(1):211-219
pubmed: 27862677
J Gynecol Oncol. 2020 Jan;31(1):e1
pubmed: 31788991
Gynecol Oncol. 1990 Sep;38(3):352-7
pubmed: 2227547
Eur J Surg Oncol. 2007 Mar;33(2):216-21
pubmed: 17097845
Cancer. 2011 Jan 15;117(2):310-7
pubmed: 20862747
Chonnam Med J. 2018 May;54(2):90-100
pubmed: 29854674
Ann Surg Oncol. 2013 Nov;20(12):3948-54
pubmed: 23812772
Clin Transl Oncol. 2015 Dec;17(12):1036-42
pubmed: 26650487

Auteurs

Yae Ji Choi (YJ)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Woo Yeon Hwang (WY)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Nara Lee (N)

Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.

Miseon Kim (M)

Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.

Dong Hoon Suh (DH)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Kidong Kim (K)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Yong Beom Kim (YB)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Jae Hong No (JH)

Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

Classifications MeSH